CGEM CULLINAN THERAPEUTICS INC

Ownership history in Caption Management, LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in CULLINAN THERAPEUTICS INC (CGEM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.05% (2025 Q2)
Avg. % of fund
0.01%
First filed
2024 Q3
Last filed
2025 Q4
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 5,800 -22,589 -79.6% 0.00% $60K $10.35
2025 Q3 REDUCED 28,389 -147,038 -83.8% 0.00% $168K $5.93
2025 Q2 REDUCED 175,427 -406,673 -69.9% 0.01% $1.3M $7.53
2025 Q2 ADDED 582,100 +559,100 +2430.9% 0.05% $4.4M $7.53
2024 Q3 REDUCED 23,000 -46,900 -67.1% 0.01% $385K $16.74
2024 Q3 INITIATED 69,900 0.02% $1.2M $16.74
% of Fund (quarterly)    CGEM price (monthly, adj. close)
← Back to Caption Management, LLC Holdings